Phase I study of recombinant interleukin-15 in combination with checkpoint inhibitors nivolumab and ipilimumab in subjects with refractory cancers. Background: The INSIGHT study evaluates feasibility ...
Relationship of microRNA expression profiles and recurrence in advanced serous ovarian carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results